LXSMU&è&½ÏgãÆ>|½Ù
)$
u ¡ n
%#p$ )$'"!"
#!"'Ø#
! "
@94E(/,)->6?'CF8D
"<A3:&+*10!2.%#$7=;5<B
h û ") b Ò Ì ") y { f") ê ¶") Ó e é#) É ¯ ±")
Bone Tissue Formation Potential of Porous Carbonate Apatite and Mesenchymal Stem Cell Growth Factor Complex
YAMAOKATAKAHIRO"), YASUDATADASHI"), KANAYAMAKEIICHI"), KITAGOMITSUNOBU"), DOIYUTAKA#)and SHIBUTANITOSHIAKI")
°ý#¡ªÃµ¾?¡ªà£ü=,/H«íß>"7:38¦G³0FIò$<£üç.JI8+
H"õ¾=?è!½Ïg!RP[Y%^V>ÃBJ4.®õ:2I8+H" !è=?»
ñ÷>sô}è(MSC).Ô2I8,G!½Ïg:38?FGF-#!BMP-#!PDGF<;.Ô2 I!RP[Y%^V:38?¥=WMV_PQLXSMU!β-]aO^QNZ.øó2I8+H"xØ!
õ¹þ¼DõÕv©¼=ïI5ÊtðLXSMU(CAP)ÅÆ.Íí2I8+H"
ëw9?RP[Y%^V:38CAPÅÆKó+8!CAP-MSC-l§½ÏgãÆK\TUÞi=
ì×3!õ·¾,E@|½ÙKÔ35""¬sÛö35CAP-MSC=½Ïg:38FGF-#*H+
?!BMP-#KÑj38"¢st¸3ãÆK¿35"ãÆK\TUÚâÞi=ì×3!%¬:(¬
=õnÐ=r35"
%¬í9?BMPz9oÜ<~õ>Äj.FI5"·¾Ãµ|½ú?%¬í9?Dzz:Ým38 MSCz!BMPz,E@FGFz?ËK¤35"A5(¬í9?BMPz>·¾|½ú.C-65"
CAPKRP[Y%^V:35MSC,E@½Ïg>Ñj?õ·¾=ðó9*H1:.¤2I5"
P%`%V#ÊtðLXSMU!»ñ÷>sô}è!ÂckèÄ´g!|½g
,=5 >6 B85 <19= 7>1;A >6 ?5@9>4>=B1; B@51B<5=B 9A B85 @575=5@1B9>= >6 ?5@9>4>=B1; B9AAC5" /85 @575=5@1B9>=
9A 3><?>A54 >6 35;;A! 7@>EB8 613B>@A! 1=4 A3166>;4A" %1@2>=1B5 1?1B9B5 81A 255= @5?>@B54 B> 25 1 31=4941B5 A316#
6>;4 <1B5@91; 6>@ 2>=5 @575=5@1B9>=" /85 ?C@?>A5 >6 B89A ABC4G E1A B> 5D1;C1B5 1 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A! E9B8 7@>EB8 613B>@ 6>@ 85B5@>B>?93 2>=5 6>@<1B9>=" /85 3><?;5F E1A 7@16B54 C=#
45@ B85 213: A:9= >6 <1BC@54 <1;5 @1BA" /85 7@16B54 <1B5@91;A 1=4 AC@@>C=49=7 A>6B B9AAC5 E5@5 @5<>D54 16B5@
%1=4(E55:A 6>@ 89AB>;>7931; ABC4G" /85 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A E9B8 2>=5
<>@?8>;>793 ?@>B59= A8>E54 B85 89785AB 2>=5 6>@<1B9>=" /85 31@2>=1B5 1?1B9B5 E1A @5A>@254 2G >AB5>3;1ABA 1=4 @5?;1354 2G =5E;G 6>@<54 2>=5 B9AAC5"
$ 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A E9B8 2>=5 <>@?8>;>793 ?@>B59= 31= 25 1 3>=#
A945@54 1 31=4941B5 6>@ ?5@9>4>=B1; 2>=5 @575=5@1B9>="
Key words: Carbonate apatite, mesenchymal stem cell, fibroblast growth factor, bone morphogenic protein, bone formation
")ÎÖÈn¡nâqÁdün ¡ªànäî
#)ÎÖÈn¡nâ
&!"&!#)' uáºææÀ"(&"
")&5?1@B<5=B >6 -5@9>4>=B>;>7G! &9D9A9>= >6 ,@1; )=653B9>=A 1=4 (51;B8
.395=35A
$A189 0=9D5@A9BG .38>>; >6 &5=B9AB@G
#)$A189 0=9D5@A9BG .38>>; >6 &5=B9AB@G (>HC<9"(&"! +9HC8>! '96C&!"&!#)'! *1?1=
(å½#(Ø""(Ö¨ù)
*%
( Ñ
óþN6áDKóþöÊI27Wâÿ²J"C F;DúV08UX»$Höʦ4ÛYXD/W"N 6áDI2/DU1)kd%t*!ã¨!Bg
íJé¿MJNPÝY>4"¿FHW"*"ÐäÞ?
·ÂJ±¾Çã¨)MSC*Zë½;@áDʦ4:
3[IËy:XD/W#*"SÊÇJ¯ ã¨E.
WMSCK!SÊîôN6F;DJÞ?ks%ã
¨J×BB I ;D/6A7EH6!:UIñ©
ã¨!Þã¨!Þã¨!Àã¨HGJbÓ¾ÇJ»$
HN6I =WÌZRB@ã¨E.W$*":UI MSCJz5F;D!ßÝy¸SepZìÉ
=W9FITV!Ty¸JR54Á@:XW 9F4_UXD/W"9JT0IMSCK°Á@æ
½Z¶;D2V!áDÊJ°p3Ud²:X!Î*
m̹4« ;D5D/W%&'*"
óþN6áDI27WBgíF;DKÞÅBí )Bone Morphogenetic Protein#BMP*(&"$*!J£ã
¨ R 5 í)Fibroblast Growth Factor-##
FGF*"%&"(*!Ê) · Â R 5 í)Platelet-Derived
Growth Factor#PDGF*")*HG4Ëy:XD/W"
ã¨ZáDÊIë½=W1Ý!öÊõJOæA2 TLÅ\º3U!ã¨Zkd%tIa:>
DÀZÛ/!DYM¬=W9F4mE.
W"**"KTVkd%tF;Dw_tdi]
y o _ s)HAP*#!&##*!β- ê é c i ` )β- TCP*#$!#%*4ý:XD5@"HAPKN69ÑA4Ë 6!Þq}IµXD/WRJJN6EJ·ý4N F[GH/"O@β-TCPKN6·ýA4ËÕE.
W4!N69ÑAIÐW9F4_UXD/W#$!#%*"HAP ZÀã¨Jkd%tF;Dë½;@1Ý!¬
ÓRHAP4gµ±Wä;IHGJÏFHW9 F4³Ò:XW"¥!β-TCPJ¼êAKã¨À Jkd%tF;DKn:H/FÙ1UXW"?
J@QÁ!?XUZ¤0åÉF;D^ê²¶]yo _s)CAP*J¶½A4d²:XD/W#&&#(*"CAPK N69ÑA2TLN6·ýAIµXW@QÞáDJk d%tF;Dµ[:XW"
?9EªÌ¹J²mKCAPXÖY0IMSCZ
ü;!¨üBgíEìÉZº1@ÝYZqs
I¬;!N6áD2TLÞÅBIC/DËy;
@"
åÉ2TL¥¦
""ÝYJæE
æE¥¦KvU#)*J¥¦I%<DæE;@"CAP
¡®FÔÈxZ"#"EßÝ;!c3IÂÄBÅZ ÛB@":UI#!!MPaF=&ÄZï;!~UX@
CAPZ"õ±4Ç=I8i;DxZ¼#;@"
¬PÓ!,Vu&,' E(!!,OE,;õ±£
ô;D¶ÖÅ&!-Z¶=WCAPXÖYZæE;@
)hÆ'mm!Ü:#mm*"
Þ?·ÂJMSCIKqsÞ?·Â±¾Çã¨
)KE-%!!!DS|\%x_br^c!<r*Z
½/@"&!m!|kgIØN6¸}`)rdh
on²¶"!mMβ-flê!&!g/m!]k g { ê!"!-FCSo¡D-MEM)Life Technolo- gies!Carlsbad!CA!USA*ZfC;@"CO#_d }%o%)$(,!&-CO#u*ID"($!±
ÀZÛ/!ÀJÔ®K$IÛB@"
CAPXÖYIØN6¸}`)#m!/well*Zo¡
;@"`o¡Ó!CAPXÖY0IMSCZ"+"!%cell /wellü;!"!±À;@)MSCÃ*"ÀÓCAP XÖYZ¯/%-y]rztIDÒk
;!QàÄsíͽ)SEM, S%&!!ÆEæ'!w º*ID°çZ;@"
MSCÀÓ!CAP-MSCIBgíF;DBMP-# )BMPÃ*!FGF-#)FGFÃ*Z u"!!ng/m!I
;DCAPXÖY0Io¡!"õ±À2TL:
>DÝYZæE;@"
#"{÷Î
÷Î{IKWistarǹAqs"!!Ï)¢¿Y
"#)!g*Z%))¨Ã%*ë½;@"DÄ7=
ID"!´ù;@~sx{o%us`)m
v~p+!»ÆE´!wº*ÚdøITW L:«>ZÛB@"û$³Zaov%ID-Ó!
j±ZÛ/¬J%ZÛB@"§¢½kID
IG¦Z¡1CAPÝYZ¬;!m|su_
ð)m|sqp!j%i%!wº*IDJ
§ÝZÛB@"O@Z.ÃF;Dã¨2TLBgí Zü;H/CAPXÖYZ|»I¬;@);"*"
¬Ó"!±EðZÛB@"
H2ªÌ¹Ke]ªóª{÷ÎÍĤJ + )No##!"!&&*Z~DÛB@"
$"ÝYJl#2TLN6ªJæE
qsZ#!²!%!²2TL)!²Itè;!÷
ÎZþJN6F¥I;Dl#;@"H2CAP
ÝY¬3UtèZÛ0OEJqsJY"ZÈT
;D!L:m¾Z© ;@"òÉKDÄ7=EH 2!¯/%-y]rztE"!±Òk;
Mc]Oa%¤*%Çátª!Ø> Çô
)&
7"6>"!)EDTA&pH'"%'3v=9#³Ü~
47"
Ü~²6!CAPרKßx:Ý4!Ý.
/æÿ=<HE,=ÏÞ4!&om>cidNnÎ&
K¦É47"
%"Ò½Î&>Ѿ
Ò½Î&?pz>Ѿ)K87!Ò½§-E
@Ò½ÖK87"
"'efaTXjn#PRYn&HE'Ѿ
â)= ´ + e f a T X j n&Sigma-Aldrich*, St.
Louis, Mo, USA'-E@PRYnMkV$k&8·
0!ڥ'K4+9Ѿ47"
#'MWn#fmj$&Azan'Ѿ
ú+?!"")M\SkgnGv&þí{0ü!ë
'=&¬Âã4!MbjnMkV$k=9#$4!
éMkV$k:ѾKä«47"6>&)jn]
nUZ`n©Å3vß:$¬!ÅÐMbjnÊ#
RlnYG©¢v&þí{0ü!ë'=9"
¬Âã47"
$'±Ì©çÆ©dQZdL]$[&TRAP'Ѿ
Ò½Î&?ÜcidNn!Naphthol AS-MX phos- phate&Sigma-Aldrich*!St. Louis!Mo!USA'K
®;49"Mé ºv:öyK87"õ¾!
!"!"N>NaOH3v=9öyKä«4!PBS=9Ð
¼!efaTXjn:Ѿ47"
&"Ò½Ö
AZANѾ=-+9pz=5#°7>ÖK
87"Ö?ê'F#)'!¡F$!'>()=EG87"
ì #Ë ?ANOVA: +!× µ ÷ &Tukey- Kramer)'=EG1r£åK87"
"'ÁÈÒ½Ç5
ÁÈÒ½Ç5?CAPרÝ.>û.Í=Ù 5HÁÈÒ½.Í>÷5K¨¶47"
#'ÁÈ Ç5
ÁÈ Ç5?ÁÈÒ½>Ó.Í=Ù5HÁÈ . Í&ÁÈÒ½ï>Ê0óÑ3I7ÿq'>÷5K¨¶
47"
}
""CAPMSC!Ø>SEM=EH§
CAPרû.?Õ|47¤*:"JI9-G!
MSC/CAPרû.:Õ|49+H2;/§
3I7&Ä#'"
#"i_aøzA>CAP!Ø,ñ
"'i_a>Mc]Oa,ñ>ص>%{
¯ß>i_a=Ù¸!¯:>ص=£
s?òCFI<.87"B7ðè=,ñÿq=w¹ öy?FI<.87"
#'HEѾ=EHÒ½è§
&"'øz,ñ%³
CAPÿ#A>Ò½>¿ñ/òCFI&Ä$%
a'!;0=BMP=-+9?CAPרßxý
B:Ò½>¿ñ/ò3I7&Ä$%b'"
&#'øz,ñ(³
(³/=-+9?Ù¸&Ä%%a';÷49BMP
&Ä%%b':EGÒ½>CAPרïA>¿
ñ/ò3I7"BMP!FGF:?£?òCF I<.87"MSC&Ä%%c'=-+9!ßÀÿ=
?Û4<+D>>Ò½>¿ñ/à-=§3I Ä""CAP!ئÉdm$^h$a
Ù¸?é|tª>uKù1H7C=!tªé|;
î2>»:*HØA,ñ47"
Ä#"CAP-MSC!Ø>SEMÔ&('!'
)&
2"
#&GHIpf9ADqeO|Uu
%!&qes
K$a6;!ycS7N/5BMPS!
FGFS*A<MSCS9*(5!CAPwZxj
9>6V\qe,g/5(D:,M.E2">2
K(a6;!BMPS!FGFS9*(5CAP wZxzhR>6w:V\qe:tL!gF
?2%k%$a!b!c!d!e!f!g!h&"
%"&ioqeTn
K"a6;!FGFS9*(5MSCS!
BMPS7N/5J9ioqe:Tn,?BE 2">2BMPS7ycS7N/2d\9*(5@
BMPS6J9V\qe:tLF?2%k&$a&"
$a9*(5ycS7:NF[42d\!MSC
S*A<BMPS!FGFS9*(5J9V\qe :tLF?!~9BMPS9*(5W{9?BE 2%k&$b&"
.B9(a6;MSCS7BMPS!FGFS7:
Q9*(5@J^F?2"23/!BMPS!FGF
SQ6;J^;?BE8+42%k&$c&"
%#&io]Tn
K"a6;BMPS9*(5]Tn:t L,vS7N/5J9?BE2"%k'$a&"
K$a9*(5@!"a}BMPS6 ]Tn:tL,J9?BE2,!1:v:S6
;J^;?BE8+42%k'$b&"
.B9K(a9*(5@"a!$a}9 BMPS9*(5]Tn:tL,W{9?BE2"
/+/MSCS7FGFS:Q6;J^;?BE 8+42%k'$c&"
$&TRAPpf9ADqeO|P`
ycS6;$a*A<(a7@9TRAPm _;?BE8+42"BMPS:$a9;V\
qe r9TRAPm_,?BE2"(a6
;ACwl:TRAPm_F?2%k($a!b&"
FGFS9*(5@}9$a!(a7@9TRAP
m_,M.E2,!BMPS7N0D7bl 6'42"
MSCS9*(5;$a6;TRAPm_;M k#"KX $aHEpfs
a#V\qe:CAPwZx r=:g,M.ED"
b#ycS7N0D7CAPwZxjr>6w-:V\qe,tL!g/5(D:
,M.ED"
c#ycS7N0D7!CAPwZx r98V\qe,g/5(D"
d#FGFS7}! r9V\qe,tL!g/zh9Y+)qe@P`.ED"
R^YS\&å&¶ÊhàÄB¶Ù
*(
× 3 N @ . : 9 /!)¢ ê A - * < C P 6 . A TRAPðµå/t×3N9"
æ}=C!ÎgK#&'AJ:<rÛ3N9CAPÃ
ÄQï49"CAPCÎgK#%!#)'!ziK#''AJL CAP¶#§ªI8Báòlv͵-JD»
¬°õµBä/3N!XV`_%b]>4<ìï=
)O+>,KNM"CAPçÖBaZ\BÄ£B ãlCŨÒîA¾mQ492>.KH!
CAPB·ÄÕçÖA-1M·ÄEBfsµC¦@*
>³3NM"3KACAPACå-JD¶Êh
BÇÄ>4<ñï5M9GA!pB =C&!(|
óQì49ÃÄQï49"ÃÄB|óC
&!(d©=ôÀ|Qì5M>¥ëK#*'/4<- L!ôÀ|Qì5M2>=å-JD¶ÊhBÇ ÄA@LÔM>,!æ =C&!(|óQì5M CAPQï49"
¶Êh>4<BMP-#!FGF-#Qï49"
íÓh=)MBMP-#CMSCQoåEâl3
7M·òwµá=)L*!$!!$"'!ALPwµ-JDPTH jϵQÉéA¿±4!TX[TUbWcB·Hí Ó5M2>.K!MSCQoåAâl37!¸q lQíÓ5M>,KN<*M$#&$%'"FGF-#CÄÕB Ã0B»¬AÁ4<*M"in vitroB}A-*<
C!oåB¾«¿±ï$&'!MSCBoåE Bâl$''/ä3N!~Ø¡»¬·=B/±
GKN<*M"
aZ\ÚßÝkACAPàÄBçÖQ*!
»¬-JD»¬B¶BãlA;*< Ð49"8 Bn!»¬B¾móA-*<CçÖ{y/Ê*
Ì!Ũ>Üu4<MSC=ìeA¾m4!3K ABMP!FGFA-*<CìeA¾m5Mn
>@:9"2BnJL!CAP-MSC-¶ÊhàÄ /·ÄÕ=B»¬·AìñAÑ02>/3N 9"»¬B¶óA-*<C?BçÖ{yA-*<
H!BMP-#/»¬¶¿±QìeA×GMn>
@:9"2NCº¤BËLBMP-#AJMMSCEB
ïAJL¸ql/¿±3N99G=)M>³3N M"4.4@/KpÂB¶ÊhA-*<CMSC
²%"ÝkçÖ )¢HE¹½ a$CAP|ßâAC%¢ê>ÒîA»¬/×GKNM"
b$CAPÃÄÕACôB»¬Q×G!ȯßAF=»¬B®Ö/x3NM"
c$ÃÄBȯßAH!è@»¬B®ÖQ×GM"
d$ȯßF=Æ4@*HBBÞ¼ßB»¬/¾m/É=)M"
$#
V""ABCXR[
a#GKjk53JLYQ3Sd?e8<'!aTj53Sd4>,&/$<"
b#](3JLYQ3\D'Ee)=!hZiH/4W(fX)=-jk'Ee)=!M YQ0N>=<['Ee)=<"
c#_PI0gF+<0!CAP]K^hZj2:;](3JLYQ'Sd*.%<"
d#FGFI0cn!hZj2JLYQ'\D!Sd*.%<"
e#!Omcn!CAP]K^hZiH2.JLYQ?e8<"
f#!Om0g6aTj53JLYQ3Sd'U@/%<"
g#!Om0g6aTj53JLYQ3Sd'bl/$<"
h#aTj7/`*1%933hZj3JLYQ'\D*.%<"
IQMJO%u%Wxn<oc
)) b9\35n!¢VrHA:/65"CAP kHFGF<937o?35v;=¦j :d[0DF5#''0!Y?<zh8=!FGF b;.-B¦j:lc=ADF:/65"
CAP-MSC-Wxn<TNOY8<oc
?<XaH^w3591G!CAP0MSC.C>
Wx<¦j:LKSR$UP9:E19!@5
MSC0dn.C>o<s;.-7|¤:
¡]H[54190yq2F5"2D;BMP-"H
Z4E198l<c02FE19By2F 5"3/3g`;.-7=<Wx;.-7=
¦j:d[0DF:/655A!piZe<~
u:f0¤8,E"
'"
a#BMPb8¢V;Z37-E"
b#"{ £!${ ;.-7BBMPb;.-7oc
¥<ZH¢V;AE"
c#({ 8B£;BMPb8oc¥=tBm-"
&"
&n)$($b'
a#FGFb;¢VrHAE"+p*!"!%
b#}b9<b9<_;¢VrHAE"
c#BMPb!FGFb;.-70¢V;Z37 -E0!BMPb!FGFb8=¢VrHA:-"
"!!
6
""Æ Ý r ª GCAP-MSCö Ö : á y 4 E 1 8 7!ͺ;¼ÇG+l:Ò¾4E18.®2F 5"
#"BMP-#GCAP-MSCöÖ:áy4E187!
ÆG+l:Ò¾4E18.®2F5"
i¶;z-C!CAPGSLb_%fY835 MSC,B=ÆÝrª;áy<ͺ¼Ç:+.7)E 18.®£2F5"
2sÏð'COI(
#6ù:36!~®4?/2sÏð·×<9*"
ù
"(Langer R and Vacanti JP. Tissue Engineering.*-1/4-/!
"**$;#'!:*#!&*#'.
#(Kawaguchi H, Hirachi A, Hasegawa N, Iwata T, Hama- guchi H, Shiba H, Takata T, Kato Y and Kurihara H.
Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells.' (/715.54952!#!!%;(&:"#)"&"#)(.
$(Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells.*-1/4-/!"***;
#)%:"%$&"%(.
%(Nauta AJ and Fibbe WE. Immunomodulatory proper- ties of mesenchymal stromal cells."255.!#!!(;""!:
$%**&$&!'.
&(Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K and Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells."255.!#!!(;"!*:##)&#$%.
'(Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic proper-
ties of differentiated and undifferentiated mesenchy- mal stem cells.%<6 &/3,952!#!!$;$":)*!&)*'. ((Fromigué O, Marie PJ and Lomri A. Bone morphoge-
netic protein-#and transforming growth factor-beta
#interact to modulate human bone marrow stromal cell proliferation and differentiation. ' #/22 "15-0/3!
"**);'):%""&%#'.
)(Kobayashi M, Takiguchi T, Suzuki R, Yamaguchi A, Deguchi K, Shionome M, Miyazawa Y, Nishihata T, Nagumo M and Hasegawa K. Recombinant human bone morphogenetic protein-#stimulates osteoblastic differentiation in cells isolated from human periodontal ligament.' $/49 )/8!"***;():"'#%&"'$$.
*(Kadowaki A, Tsukazaki T, Hirata K, Shibata Y, Okubo Y, Bessho K, Komori T, Yoshida N and Yamaguchi A.
Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-#from calvariae of GFP transgenic mice."54/!
#!!%;$%:**$&"!!$.
"!(#²q"oâª4#Í@ +HW\JIfS^M
U%:BDBMP#oâªGçì35/¥ÿm¸
:BE ¤Ç"§p"#!!%$#)#("&(("
""(jæ"!yæ8!ý(!è"¬°4>;Bone mor- phogenetic protein'BMP(;u.:4E&e Ph]ZhXBMPïPd%Oh$:BE Æ;
¦&"묰«""**%$$'#&'&''"
"#(ÈÔ¨!³ãåܽ!Ê5}"rhBMP-#:BE
¬°Íº¤Ç8 Å*Û1Äþ;Ýßòx"묰
«"#!!#$%%#$('&$)'"
"$(yæ´¿!-©!ÂÙü!Ê5}""ûÅ
Ó:,0E¬¡µ{¯ñ'>;BMP-#äõ:BE¬
°Íº¤Çz"묰«"#!!($%*##*'&$!%"
"%(~,¨!±éÚ¢!ØÞ"!v#à"ê øw;
RNZehNaK[T`&FGFRNZf;)&"
#544/-91;/ +188:/!"**(;#*:#"*&##'.
"&(Ozono S, Fujita T, Matsuo M, Todoki K, Ohtomo T, Negishi H and Kawase T. Co-treatment with basic fi- broblast growth factor and"(beta-estradiol in the presence of dexamethasone accelerates bone forma- tion by rat bone marrow stromal cell culture. ' '64 (758905.549 *5-!#!!);&#:$''&$(%.
"'(ú%7!Éô"FGF-#:BEÎß¼Ç
ÄaK[T`"&"#!!%$%%#"&"&"&'"
"((ú%7"¼Çrª#bFGF/FGF-#tÅÌn
|¥ÿѹrª"&"#!!'$%'##*(&$!$"
")(Goto H, Matsuyama T, Miyamoto M, Yonamine Y and Izumi Y. Platelet-rich plasma/osteoblasts complex in- duces bone formation via osteoblastic differentiation following subcutaneous transplantation.' (/715.549,2 )/8!#!!';%":%&&&%'#.
"*(ÊÃÚî"¬°Íº¤ÇGÒ4Ç3Å÷¯8¥ÿ4
þ:4EXdhSg%RcZfeQ%V"묰
À)"TRAPË»Ð
a#ͺñÎó:TRAP0Å¥ÿ.í7/E"
b#¼Çͺ°k:ÕÁ;TRAP0Å¥ÿGíAE"
<JD=F&Ø&®ÀUÔ¶4v®Ë
"!"
"#!"!%&#$$&"$"
#!(oÒ¤!PsİÏ!}±s!íǹá!Ä¿84 :!²Ä¯"H=GO?A<JD=F×Â4Àk x_£é3/*0"""µä+95µ4¥
z"Ê!"**(%$*$$'"&$'("
#"(~ÚTÍ!èÁ!Õ¯Û!te|!ÖSÏ
!¨S"MEFÎY64H=GO?A<JD=F )}ØH=KNEG¶R¦39;Qv
®"Ê""**(%$*$&!$&&"#"
##(~ÚTÍ!te|![T!Þºæ!èT !
¬}§T!¨S"b-FGF,b¼¶)}Ø H=KNEG¶4Qv®3+97.^"Ê
"#!!"%%$$&#&'%"
#$(Metsger DS, Drinskell TD and Paulstrud JR. Trical- cium phosphase ceramics, a resorbable bone implant, review and current status.) "6 %07< ";;8/!"*)#;"!&:
"!$&&"!$).
#%(ÆSÙ"½gß<JD=FI=>CMLE@B"Ê
ã"#!"%%$$$'&&(""
#&(ÆSÙ!ÄlW!´å¯É!¡±T!Çæ·!
m«Ñ!©ìÙ"½gß<JD=F4¢y"]
ç#ia""**&%"%$$"$&$#!"
#'(hVd!» !ÆSÙ!©ìÙ!há"
×Â2-04¢y½gß<JD=F4ÌâØ1 4ÐZ"jc"#!!"%#)$*!&"!""
#((¡\Ü"½<JD=Fw×Â"ÓX¸"
#!!(%$$$""*&"$""
#)(Doi Y, Koda T, Wakamatsu N, Goto T, Kamemizu H, Moriwaki Y, Adachi M and Suwa Y. Influence of car- bonate on sintering of apatite. ) %07< ,0;!"**$;(#:
"#(*&"#)%.
#*(ÝTê!ªÄën!fYq!uà³!t¾"
Hydroxyapatite Ceramics4rÅ2ÃÈË3/*0 4{p"Êv`""**$%"$$&'"&&(""
$!(Rickard DJ, Sulivan TA, Shenker BJ, Leboy PS and Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dex- amethasone and BMP-#.%0> #485!"**%;"'":#")&##).
$"(Kim IS, Song YM, Cho TH, Park YD, Lee KB, Noh I, Weber F and Hwang SJ. In vitro response of primary human bone marrow stromal cells to recombinant hu- man bone morphogenetic protein-#in the early and late stages of osteoblast differentiation. %0>0589 ':8?<3 %4110:!#!!);&!:&&$&&'%.
$#(Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T and Yoshiki S. Recom- binant human bone morphogenetic protein-#stimu- lates osteoblastic maturation and inhibits myogenic differentiation in vitro.) $055 #485!"**";""$:'()&')".
$$(Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang X, Soo C, Ting K and Wu B. Micro CT evaluation of three-dimensional mineralization in response to BMP-
#doses in vitro and in critical sized rat calvarial de- fects.-4;;=0 &72!#!!(;"$:&!"&&"#.
$%(Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A and Suzuki F. Bone morphogenetic pro- teins'BMP-#and BMP-$(promote growth and expres- sion of the differentiated phenotype of rabbit chondro- cytes and osteoblastic MC$T$-E"cells in vitro. )
#870 *470: ,0;!"**";':"$($&"$)&.
$&(Thomson BM, Bennett J, Dean V, Triffitt J, Meikle MC and Loveridge N. Preliminary characterization of por- cine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexametha- sone, transforming growth factor beta, and basic fibro- blast growth factor.) #870 *470: ,0;!"**$;):""($&
"")$.
$'(Pitaru S, Kotev ES, Noff D, Kaffuler S and Savion N. Ef- fect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells:
enhanced development of mineralized bone-like tissue in culture.) #870 *470: ,0;!"**$;):*"*&*#*.
$((K Keiichi, K Mitsunobu, S Masafumi, D Yutaka and S Toshiaki. Induction of new bone by basic FGF-loaded porous carbonate apatite implants in femur defects in rats.$547 +:.5 (695.7 ,0;!#!!*;#!:&'!&&'&.